Cascade carrier-testing in cystic fibrosis

Paediatric Respiratory Reviews

Volumn 4, Issue 4, 2003, Pages 293-298

  Roberts, Theresa ^a   Schwarz, Martin J ^a   Kerr Liddell, Rowan ^b   Hinks, Joanna L ^a   Super, Maurice ^a  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Carriers; Cascade carrier testing; Cystic fibrosis

Indexed keywords

CLINICAL LABORATORY; CYSTIC FIBROSIS; FAMILY HISTORY; GENETIC COUNSELING; GENETIC SCREENING; HEALTH PROGRAM; HETEROZYGOTE DETECTION; HUMAN; MASS SCREENING; MEDICAL PRACTICE; MOLECULAR GENETICS; NEWBORN SCREENING; PARENT COUNSELING; PRIORITY JOURNAL; RELATIVE; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0345169968     PISSN: 15260542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(03)00096-4     Document Type: Article

References (23)

1. United States Congress Office of Technology Assessment. Cystic Fibrosis and DNA Tests: Implications for Carrier Screening. Washington, DC: US Government Printing Office, 1992.
2. NIH Consensus Development Statement: Genetic Testing for Cystic Fibrosis. 1997. NIH Consensus Statement Online 1997; 15(4): 1-37.
3. Murray J, Cuckle H, Taylor G, Littlewood J, Hewson J. Screening for Cystic Fibrosis. Health Technol Assess 1999; 3(8). Available at www.hta.nhs/web.nhs.uk.
4. Krawecak M, Cooper DN, Schmidtke J. Estimating the efficacy and efficiency of cascade genetic screening. Am J Hum Genet 2001; 69: 361-370.
5. Super M, Schwarz Ellis RG, Ivison A, Giles L, Read AP, Harris R. Clinic experience of prenatal diagnosis of cystic fibrosis by use of linked DNA probes. Lancet 1987; 2(8562): 782-784.
6. Super M. The gene defect in cystic fibrosis and clinical applications of the knowledge. J Roy Soc Med 1992; 85(Suppl. 19): 6-8.
7. Super M, Schwarz MJ, Malone G, Roberts T, Haworth A, Dermody G. Active cascade testing for cystic fibrosis. BMJ 1994; 308: 1462-1467.
8. Balfour-Lynn, Madge I, Dinwiddie R. Testing carrier status in siblings of patients with cystic fibrosis. Arch Dis Child 1995; 72: 167-168.
9. Ferrie RM, Schwarz MJ, Robertson S et al. Development, multiplexing and application of ARMS tests for common mutations of the CFTR gene. Am J Hum Genet 1992; 51: 251-262.
10. Malone G, Haworth A, Schwarz MJ, Cuppens H, Super M. Detection of five novel mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in Pakistani paients with cystic fibrosis. Hum Mutat 1998; 11: 152-157.
11. Kiesewetter S, Macek M Jr, Davis C et al. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993; 5: 274-277.
12. Clarke JT, Skomorowski MA, Zuker S. Tay-Sachs disease carrier screening: follow-up of a case-finding approach. Am J Med Genet 1989; 34: 601-605.
13. Super M, Barnes R, Greig D. Failure to refer for testing for cystic fibrosis. BMJ 2001; 322: 311-312.
14. Parsons EP, Clarke AJ, Bradley DM. Implications of carrier identification in newborn screening in cystic fibrosis. Arch Dis Child (in press).
15. Super M. Newborn screening for cystic fibrosis: detection of carriers. Arch Dis Child (in press).
16. Wheeler PG, Smith R, Dorkin H, Parad RB, Comeau AM, Bianchi D. Genetic counseling after implementation of statewide cystic fibrosis screening: two years' experience in one medical centre. Genet Med 2001; 3(6): 411-415.
17. Evers-Kiebooms G, Denayer L, Welkhuysen M, Cassiman JJ, Van Berghe H. A stigmatising effect of the carrier state for cystic fibrosis? Clin Genet 1994; 46: 336-343.
18. Denayer L, Welkenhuysen M, Evers-Kiebooms G, Cassiman JJ, Van Berghe H. The CF carrier status is not associated with a diminished self-concept or increased anxiety: results of psychometric testing after at least 1 year. Clin Genet 1996; 49: 232-236.
19. Pier GB, Grout M, Tanweer Z et al. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 1998; 393: 79-82.
20. Surh LC, Capelli M, MacDonald NE, Mettler G, Dales RE. Cystic fibrosis carrier screening in a high-risk population. Participation based on a traditional recruitment process. Arch Pediatr Adolesc Med 1994; 148: 632-637.
21. Callanan NP, Cheuvront BJ, Sorenson JR. CF carrier testing in a high risk population: anxiety, risk perceptions and reproductive plans of carrier and "non-carrier" couples. Genet Med 1999: 1: 323-327.
22. Conway SP, Allenby K, Pond MN, Patient and parental attitudes towards genetic screening and its implications at an adult cystic fibrosis centre. Clin Genet 1994; 45: 308-312.
23. Payne Y, Williams M, Cheadle J et al. Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. The South Wales Cystic Fibrosis Carrier Research Team. Clin Genet 1997; 51: 153-163.